Tags |
|
|
Links |
|
|
Digg It - Ezine Publishing - How to Track Email and Title Effectiveness
Your autoresponder service should give you the ability to track ope
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
n rates and click through rates. Along with looking at the convers
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ion rate of each of the sales promotions you offer, that is about a
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
ll the information you need to determine your email effectiveness.
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
Over time, you will notice a pattern – your list will buy certain
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
types of products and not others. Over time, the open rate of your
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
list will go down. The reason for that is that people who have be
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
en on your list longer will not open as many emails. As your email
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
list gets older, and the average length of time that the average s
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
ubscriber has been on your list increases, your email open rate wil
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
l go down. The same can happen with the click through rate, althou
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
gh I think that with the proper communication and relationship buil
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ding with your list, that your click through rate of opened emails
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
can stay higher (at least not dropping at the same rate as the open
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
rate will drop).
How to Test Title Effectiveness
The key here is
How to Test Title Effectiveness
The key here is
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
the open rate. Assuming that your relationship with your subscrib
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
ers is constant, and assuming that you mail at the same time of the
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
day, and on the same day of the week (open rates tend to fluctuate
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
according to time and the day of the week), then the effectiveness
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
of your title or subject line will be evidenced in your open rate.
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/63271/diggit-Ezine-Publishing--How-to-Track-Email-and-Title-Effectiveness.html">Ezine Publishing - How to Track Email and Title Effectiveness</a>
BB link (for phorums):
[url=http://www.diggit.org.ua/article/63271/diggit-Ezine-Publishing--How-to-Track-Email-and-Title-Effectiveness.html]Ezine Publishing - How to Track Email and Title Effectiveness[/url]
Related Articles:
Fascinating Ways to Make a Living Doing What You Love May Be Closer Than You Think...
Growing Your Network of People Can be Easy and Fun!
How to get Reciprocal Links to your Website
Bookmark it:
|